Clorox (NYSE:CLX) Given New $173.00 Price Target at JPMorgan Chase & Co.

Clorox (NYSE:CLX) had its price target raised by JPMorgan Chase & Co. from $171.00 to $173.00 in a report issued on Tuesday,Benzinga reports. The brokerage currently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s price target indicates a potential upside of 14.09% from the company’s previous close.

Several other research firms have also issued reports on CLX. Wells Fargo & Company boosted their price target on Clorox from $157.00 to $161.00 and gave the company an “equal weight” rating in a report on Tuesday. Royal Bank of Canada reissued a “sector perform” rating and issued a $150.00 price objective on shares of Clorox in a research note on Thursday, January 30th. Barclays lowered their target price on shares of Clorox from $139.00 to $130.00 and set an “underweight” rating on the stock in a research note on Friday, January 17th. StockNews.com lowered Clorox from a “buy” rating to a “hold” rating in a research note on Sunday, January 5th. Finally, DA Davidson lifted their price target on shares of Clorox from $153.00 to $171.00 and gave the company a “neutral” rating in a report on Monday, November 4th. Four analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has issued a buy rating to the stock. According to data from MarketBeat.com, Clorox has an average rating of “Hold” and an average price target of $156.50.

Clorox Stock Down 5.1 %

Clorox stock traded down $8.14 during trading hours on Tuesday, hitting $151.64. The stock had a trading volume of 1,260,216 shares, compared to its average volume of 1,128,591. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08. Clorox has a 12-month low of $127.60 and a 12-month high of $171.37. The stock has a market capitalization of $18.77 billion, a P/E ratio of 52.74, a price-to-earnings-growth ratio of 2.92 and a beta of 0.42. The stock’s 50-day moving average price is $162.76 and its 200-day moving average price is $158.50.

Clorox (NYSE:CLX) last announced its earnings results on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.39 by $0.16. Clorox had a return on equity of 316.08% and a net margin of 4.78%. During the same period in the previous year, the business earned $2.16 EPS. Equities research analysts anticipate that Clorox will post 6.86 EPS for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the stock. Brooklyn Investment Group raised its holdings in Clorox by 163.8% in the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock valued at $25,000 after acquiring an additional 95 shares in the last quarter. Prospera Private Wealth LLC purchased a new stake in shares of Clorox during the 3rd quarter worth $27,000. Continuum Advisory LLC grew its stake in shares of Clorox by 300.0% during the third quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock worth $30,000 after purchasing an additional 138 shares in the last quarter. Asset Planning Inc purchased a new position in Clorox in the fourth quarter valued at $32,000. Finally, Carolina Wealth Advisors LLC acquired a new stake in Clorox in the third quarter valued at $48,000. Hedge funds and other institutional investors own 78.53% of the company’s stock.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.